siRNA-ART4

N/A

Report date: 2025/08/27 15:48:12
NMEFirst In Class

Base Information

Drug NamesiRNA-ART4
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAlagille Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Angtuo Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Angtuo Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAlagille Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A